1. Home
  2. DCTH vs OBE Comparison

DCTH vs OBE Comparison

Compare DCTH & OBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • OBE
  • Stock Information
  • Founded
  • DCTH 1988
  • OBE 1979
  • Country
  • DCTH United States
  • OBE Canada
  • Employees
  • DCTH N/A
  • OBE N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • OBE Oil & Gas Production
  • Sector
  • DCTH Health Care
  • OBE Energy
  • Exchange
  • DCTH Nasdaq
  • OBE Nasdaq
  • Market Cap
  • DCTH 394.9M
  • OBE 411.1M
  • IPO Year
  • DCTH N/A
  • OBE N/A
  • Fundamental
  • Price
  • DCTH $10.89
  • OBE $6.09
  • Analyst Decision
  • DCTH Strong Buy
  • OBE Buy
  • Analyst Count
  • DCTH 4
  • OBE 2
  • Target Price
  • DCTH $24.50
  • OBE $11.50
  • AVG Volume (30 Days)
  • DCTH 825.0K
  • OBE 271.0K
  • Earning Date
  • DCTH 08-06-2025
  • OBE 07-30-2025
  • Dividend Yield
  • DCTH N/A
  • OBE N/A
  • EPS Growth
  • DCTH N/A
  • OBE N/A
  • EPS
  • DCTH 0.06
  • OBE N/A
  • Revenue
  • DCTH $70,240,000.00
  • OBE $508,849,882.00
  • Revenue This Year
  • DCTH $160.46
  • OBE N/A
  • Revenue Next Year
  • DCTH $42.87
  • OBE $2.15
  • P/E Ratio
  • DCTH $195.18
  • OBE N/A
  • Revenue Growth
  • DCTH 491.35
  • OBE 1.49
  • 52 Week Low
  • DCTH $8.08
  • OBE $3.88
  • 52 Week High
  • DCTH $18.23
  • OBE $7.27
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 48.16
  • OBE 61.05
  • Support Level
  • DCTH $10.06
  • OBE $5.52
  • Resistance Level
  • DCTH $10.81
  • OBE $5.71
  • Average True Range (ATR)
  • DCTH 0.71
  • OBE 0.17
  • MACD
  • DCTH 0.13
  • OBE 0.02
  • Stochastic Oscillator
  • DCTH 28.57
  • OBE 91.87

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About OBE Obsidian Energy Ltd.

Obsidian Energy Ltd is an intermediate-sized oil and gas producer with strategic assets in Alberta. It operates in a single reporting segment that is exploration, development, and holding an interest in oil and natural gas properties and related production infrastructure in the Western Canada Sedimentary Basin. The company generates the majority of the revenue from the Crude oil sale.

Share on Social Networks: